CTIS newsflash - 27 May 2025
Submitted by Anonymous (not verified) on 27 May 2025 - 13:52
CTIS newsflash - 27 May 2025
List of centrally authorised products with safety-related changes to the product information
Submitted by Anonymous (not verified) on 27 May 2025 - 13:51
List of centrally authorised products with safety-related changes to the product information
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025
Submitted by Anonymous (not verified) on 27 May 2025 - 13:36
Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025
EMEA-003306-PIP01-22
Submitted by Anonymous (not verified) on 27 May 2025 - 13:14
EMEA-003306-PIP01-22
PSUSA/00010355/202409
Submitted by Anonymous (not verified) on 27 May 2025 - 12:54
PSUSA/00010355/202409
Quality of medicines questions and answers: Part 1
Submitted by Anonymous (not verified) on 27 May 2025 - 12:30
Quality of medicines questions and answers: Part 1
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 27 May 2025 - 11:07
Human medicines European public assessment report (EPAR): Voxzogo, vosoritide, Date of authorisation: 26/08/2021, Revision: 6, Status: Authorised
Medicine Shortages Single Point of Contact (SPOC) Working Party
Submitted by Anonymous (not verified) on 26 May 2025 - 16:24
Medicine Shortages Single Point of Contact (SPOC) Working Party
ADRA project - information session for veterinary pharmaceutical industry, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2025, 14:30 (CEST) to 22 May 2025, 16:00 (CEST)
Submitted by Anonymous (not verified) on 26 May 2025 - 16:16
ADRA project - information session for veterinary pharmaceutical industry, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 May 2025, 14:30 (CEST) to 22 May 2025, 16:00 (CEST)
Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised
Submitted by Anonymous (not verified) on 26 May 2025 - 15:39
Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Date of authorisation: 12/09/2024, Revision: 2, Status: Authorised